These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32084325)

  • 1. Mural Cell SDF1 Signaling Is Associated with the Pathogenesis of Pulmonary Arterial Hypertension.
    Yuan K; Liu Y; Zhang Y; Nathan A; Tian W; Yu J; Sweatt AJ; Shamshou EA; Condon D; Chakraborty A; Agarwal S; Auer N; Zhang S; Wu JC; Zamanian RT; Nicolls MR; de Jesus Perez VA
    Am J Respir Cell Mol Biol; 2020 Jun; 62(6):747-759. PubMed ID: 32084325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage Tracing Reveals the Dynamic Contribution of Pericytes to the Blood Vessel Remodeling in Pulmonary Hypertension.
    Bordenave J; Tu L; Berrebeh N; Thuillet R; Cumont A; Le Vely B; Fadel E; Nadaud S; Savale L; Humbert M; Huertas A; Guignabert C
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):766-782. PubMed ID: 31969018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.
    Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C
    Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Endothelium-Derived Wnt5a Is Associated With Reduced Pericyte Recruitment and Small Vessel Loss in Pulmonary Arterial Hypertension.
    Yuan K; Shamskhou EA; Orcholski ME; Nathan A; Reddy S; Honda H; Mani V; Zeng Y; Ozen MO; Wang L; Demirci U; Tian W; Nicolls MR; de Jesus Perez VA
    Circulation; 2019 Apr; 139(14):1710-1724. PubMed ID: 30586764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes contribute to pulmonary vascular remodeling via HIF2α signaling.
    Kim H; Liu Y; Kim J; Kim Y; Klouda T; Fisch S; Baek SH; Liu T; Dahlberg S; Hu CJ; Tian W; Jiang X; Kosmas K; Christou HA; Korman BD; Vargas SO; Wu JC; Stenmark KR; Perez VJ; Nicolls MR; Raby BA; Yuan K
    EMBO Rep; 2024 Feb; 25(2):616-645. PubMed ID: 38243138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia.
    Wei L; Zhang B; Cao W; Xing H; Yu X; Zhu D
    J Recept Signal Transduct Res; 2015; 35(4):329-39. PubMed ID: 25421526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Wnt/planar cell polarity pathway is required for pericyte recruitment during pulmonary angiogenesis.
    Yuan K; Orcholski ME; Panaroni C; Shuffle EM; Huang NF; Jiang X; Tian W; Vladar EK; Wang L; Nicolls MR; Wu JY; de Jesus Perez VA
    Am J Pathol; 2015 Jan; 185(1):69-84. PubMed ID: 25447046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell-derived factor 1 (SDF1) attenuates platelet-derived growth factor-B (PDGF-B)-induced vascular remodeling for adipose tissue expansion in obesity.
    Watanabe E; Wada T; Okekawa A; Kitamura F; Komatsu G; Onogi Y; Yamamoto S; Sasahara M; Kitada M; Koya D; Tsuneki H; Sasaoka T
    Angiogenesis; 2020 Nov; 23(4):667-684. PubMed ID: 32699964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular retention of PDGF-B directs vascular remodeling in mouse hypoxia-induced pulmonary hypertension.
    Tannenberg P; Chang YT; Muhl L; Laviña B; Gladh H; Genové G; Betsholtz C; Folestad E; Tran-Lundmark K
    Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L593-L605. PubMed ID: 29212800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.
    Guignabert C; Alvira CM; Alastalo TP; Sawada H; Hansmann G; Zhao M; Wang L; El-Bizri N; Rabinovitch M
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1082-90. PubMed ID: 19801450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of smooth muscle cell hypoxia inducible factor-1α underlies increased vascular contractility in pulmonary hypertension.
    Barnes EA; Chen CH; Sedan O; Cornfield DN
    FASEB J; 2017 Feb; 31(2):650-662. PubMed ID: 27811062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis.
    Ozerdem U; Grako KA; Dahlin-Huppe K; Monosov E; Stallcup WB
    Dev Dyn; 2001 Oct; 222(2):218-27. PubMed ID: 11668599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway.
    Huang X; Zou L; Yu X; Chen M; Guo R; Cai H; Yao D; Xu X; Chen Y; Ding C; Cai X; Wang L
    J Mol Cell Cardiol; 2015 May; 82():153-66. PubMed ID: 25772255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways.
    Liu Y; Cao Y; Sun S; Zhu J; Gao S; Pang J; Zhu D; Sun Z
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):141-154. PubMed ID: 27297622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin ameliorates hypoxia-induced pulmonary hypertension associated with down-regulated stromal cell-derived factor-1.
    Satoh K; Fukumoto Y; Nakano M; Sugimura K; Nawata J; Demachi J; Karibe A; Kagaya Y; Ishii N; Sugamura K; Shimokawa H
    Cardiovasc Res; 2009 Jan; 81(1):226-34. PubMed ID: 18779230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of endoplasmic reticulum stress by 4-phenylbutyric acid prevents the development of hypoxia-induced pulmonary arterial hypertension.
    Koyama M; Furuhashi M; Ishimura S; Mita T; Fuseya T; Okazaki Y; Yoshida H; Tsuchihashi K; Miura T
    Am J Physiol Heart Circ Physiol; 2014 May; 306(9):H1314-23. PubMed ID: 24610918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of prolyl hydroxylase domain protein 2 in vascular endothelium increases pericyte coverage and promotes pulmonary arterial remodeling.
    Wang S; Zeng H; Xie XJ; Tao YK; He X; Roman RJ; Aschner JL; Chen JX
    Oncotarget; 2016 Sep; 7(37):58848-58861. PubMed ID: 27613846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.